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Developing an assay for 
Polar Organizing Protein Z (PopZ) mutant screening
The long-standing model that protein structure is critical to function has been
expanded to include intrinsically disordered proteins (IDPs). IDPs facilitate several
biological functions and have significance to human health. IDPs lack stable
structures and exist more as conformational ensembles making studying IDP
structure more challenging. The mechanisms of polar organization in bacteria are
being used to study IDP structure experimentally. Recent efforts have exploited
the mechanisms of polar organization with the IDP PopZ in E. coli to identify
several PopZ protein binding partners. Four recombinant E. coli strains with PopZ
and known protein binding partner plasmids were used to develop an assay. This
assay was based on protocols for the purification of PopZ and many binding
partners. Liquid cultures for the four strains were inoculated, diluted, and
induced with IPTG and arabinose. Slides were then prepared for fluorescent
microscopy. PopZ was labeled with mCherry. The binding partners and control
protein were labeled with GFP. PopZ and mutant PopZ exhibited polar
localization. GFP and mCherry polar localization resulted from binding between
PopZ and the ChpT and ParB strains. Diffused GFP was observed for both DivK
and the mutant PopZ with ParB strains. These results verified the effectiveness
and accuracy of the assay. Detailed protocols were written for PopZ mutant
screening, planned for the summer of 2017 at UW-Casper. Future work will
include modifications to the concentration of IPTG and arabinose to assure the
appropriate levels of protein expression during screening.
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Ordered proteins require a folding pattern that forms a structure that is specific to
the function it performs. Intrinsically disordered proteins (IDPs) have regions of
amino acid sequences that do not have a definite folding pattern, but are still able
to function similarly to an ordered protein (1). When an IDP encounters a binding
partner, the disordered region will fold specifically to bind with that partner. IDPs
can have numerous binding partners and cellular functions (2). When mutated,
some IDPs have been discovered to be associated with certain diseases, including
cancer (2). One example is human protein, p53 (3). A connection between p53
function and cancer has been identified with about half of all human cancers
having mutations in p53 (4). Studying IDPs structure-function relationship could
have many potential benefits to human health. Polar organizing protein Z (PopZ) is
an IDP found in Alphaproteobacterium Caulobacter crescentus (3). PopZ is
required for polar localization of several proteins (3). Polar localization
is important in rod-shaped bacterial cells, for example, in constructing
structures such as flagella (5).
The assay developed for this project is designed to experimentally
confirm potential positive and negative PopZ binding partners. In these
experiments, recombinant Escherichia coli (E. coli) was used to express the
recombinant proteins which are fused with GFP and mCherry fluorescent markers
(Table 1). Visualization of proteins in the cell verified whether the PopZ protein
was interacting with the specified binding partner. The purpose of these efforts is
to finalize an assay to be used with PopZ mutants.
Fluorescent microscopy observations offered support to verify the effectiveness
and accuracy of this assay. As expected, wildtype PopZ and mutant PopZ
exhibited polar localization in all strains. Wildtype PopZ exhibited polar
localization, and the GFP-tagged binding partners, ChpT and ParB, co-localized
with the polar PopZ foci (Images 1 and 2). DivK is a known negative protein
binding partner with wildtype PopZ. While the wildtype PopZ exhibited polar
localization, the GFP-tagged DivK did not co-localize with the polar PopZ foci and
was observed to be dispersed throughout the cell (Image 3). A mutant form of
PopZ was investigated in this experiment. It localized to the cell poles, but the
ParB binding partner failed to co-localize, indicating a defect in protein-protein
interaction (Image 4).
All strains were observed to express proteins at adequate levels for verification
of the assay. The protein expression induction was performed at 0.2% wt/vol
arabinose and 100µg/µl of IPTG.
The observed behavior and interaction of PopZ and binding partner proteins
were as expected, based on previous experiments. These results served to verify
the effectiveness and accuracy of this assay. This assay is planned to be used to
screen for co-localization with new strains that will include mutant PopZ and
many binding partners. Consistent, accurate results from the developed assay are
critical for the next phase of the project.
In these experiments, inducers are used to initiate the process of transcription
(4). The inducer concentration can be adjusted to increase or decrease gene
expression. Using too much IPTG causes excessive PopZ expression. Excessive
expression of PopZ can negatively affect the E. coli, in essence making it sick. It
can also reduce the expression of the protein binding partner. This can distort the
microscopy results and analysis of the interaction between PopZ and binding
partners. Further efforts may include modifications to the concentration of the
IPTG and arabinose inducers. Previous research has suggested a range from
50µg/µl to 500µg/µl final concentration at induction of IPTG (3). Observations
from initial results suggested that the amount of IPTG should be adjusted to a
lower concentration. The level of arabinose is not as critical to E. coli health if it
falls into the upper range of the recommended induction range, 0.02%- 2.0%
wt/vol. Our results suggested that the arabinose concentration may need to be
increased from the current 0.2% concentration for the 68, JH81, and JH160
strains. The current 0.2% concentration for the 155 strain was shown to be
adequate for expression levels.
In the next phase of the project, PopZ mutants will be created and screened for
binding with normally positive binding partners. It is hypothesized that certain
segments in the amino acid sequence of PopZ are responsible for its binding
interactions. Removing these sequences or mutating them will result in PopZ
failing to interact with a normally binding partner. These experiments will
support efforts to further understand the structure-function relationship of IDPs.
